PLN 122.5
(-2.78%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 112.71 Million PLN | 65.27% |
2022 | 68.2 Million PLN | -30.65% |
2021 | 98.34 Million PLN | 94.97% |
2020 | 50.44 Million PLN | 46.96% |
2019 | 34.32 Million PLN | 10.68% |
2018 | 31.01 Million PLN | 20.0% |
2017 | 25.84 Million PLN | 54.72% |
2016 | 16.7 Million PLN | -17.93% |
2015 | 20.35 Million PLN | 2910.16% |
2014 | 676.1 Thousand PLN | -88.98% |
2013 | 6.13 Million PLN | -21.64% |
2012 | 7.83 Million PLN | 120.14% |
2011 | 3.55 Million PLN | -18.7% |
2010 | 4.37 Million PLN | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 29.09 Million PLN | -18.7% |
2024 Q2 | 31.03 Million PLN | 5.05% |
2023 Q3 | 33.37 Million PLN | 35.3% |
2023 Q1 | 18.88 Million PLN | -10.87% |
2023 FY | 112.71 Million PLN | 65.27% |
2023 Q4 | 35.79 Million PLN | 7.25% |
2023 Q2 | 24.66 Million PLN | 30.65% |
2022 Q3 | 23.47 Million PLN | 185.14% |
2022 FY | 68.2 Million PLN | -30.65% |
2022 Q1 | 17.1 Million PLN | -55.67% |
2022 Q2 | 8.23 Million PLN | -51.89% |
2022 Q4 | 21.18 Million PLN | -9.75% |
2021 FY | 98.34 Million PLN | 94.97% |
2021 Q1 | 22.33 Million PLN | -13.86% |
2021 Q2 | 27.7 Million PLN | 24.07% |
2021 Q3 | 13.7 Million PLN | -50.53% |
2021 Q4 | 38.59 Million PLN | 181.58% |
2020 Q4 | 25.92 Million PLN | 59.06% |
2020 FY | 50.44 Million PLN | 46.96% |
2020 Q3 | 16.29 Million PLN | 2196.03% |
2020 Q2 | -777.6 Thousand PLN | -108.65% |
2020 Q1 | 8.99 Million PLN | -9.96% |
2019 Q4 | 9.98 Million PLN | 13.23% |
2019 Q3 | 8.82 Million PLN | 8.95% |
2019 Q2 | 8.09 Million PLN | 9.18% |
2019 Q1 | 7.41 Million PLN | -37.02% |
2019 FY | 34.32 Million PLN | 10.68% |
2018 FY | 31.01 Million PLN | 20.0% |
2018 Q2 | 5.65 Million PLN | 7.39% |
2018 Q4 | 11.77 Million PLN | 41.65% |
2018 Q3 | 8.31 Million PLN | 46.99% |
2018 Q1 | 5.26 Million PLN | -55.84% |
2017 Q4 | 11.92 Million PLN | 99.93% |
2017 Q3 | 5.96 Million PLN | 104.51% |
2017 FY | 25.84 Million PLN | 54.72% |
2017 Q1 | 5.03 Million PLN | -28.76% |
2017 Q2 | 2.91 Million PLN | -42.01% |
2016 Q3 | 2.8 Million PLN | -33.6% |
2016 Q2 | 4.22 Million PLN | 61.8% |
2016 Q4 | 7.06 Million PLN | 151.76% |
2016 FY | 16.7 Million PLN | -17.93% |
2016 Q1 | 2.61 Million PLN | -56.66% |
2015 Q4 | 6.02 Million PLN | 68.82% |
2015 Q1 | 4.07 Million PLN | 354.99% |
2015 Q2 | 5.21 Million PLN | 28.11% |
2015 Q3 | 3.56 Million PLN | -31.61% |
2015 FY | 20.35 Million PLN | 2910.16% |
2014 Q3 | -181.2 Thousand PLN | -311.68% |
2014 FY | 676.1 Thousand PLN | -88.98% |
2014 Q4 | -1.59 Million PLN | -781.4% |
2014 Q2 | 85.6 Thousand PLN | -96.39% |
2014 Q1 | 2.36 Million PLN | 40.05% |
2013 Q2 | 887.1 Thousand PLN | -64.96% |
2013 Q4 | 1.69 Million PLN | 64.89% |
2013 Q3 | 1.02 Million PLN | 15.64% |
2013 FY | 6.13 Million PLN | -21.64% |
2013 Q1 | 2.53 Million PLN | -46.49% |
2012 Q4 | 4.73 Million PLN | 479.11% |
2012 Q1 | 2.16 Million PLN | -42.82% |
2012 Q2 | 110.4 Thousand PLN | -94.9% |
2012 Q3 | 817 Thousand PLN | 640.04% |
2012 FY | 7.83 Million PLN | 120.14% |
2011 Q3 | 131 Thousand PLN | 0.0% |
2011 FY | 3.55 Million PLN | -18.7% |
2011 Q4 | 3.78 Million PLN | 2789.83% |
2010 FY | 4.37 Million PLN | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
BioMaxima S.A. | 201 Thousand PLN | -55978.756% |
Scope Fluidics S.A. | -28.68 Million PLN | 492.979% |
Selvita S.A. | 69.31 Million PLN | -62.627% |